Pursuant to the transaction with Telix, ImaginAb has retained its lead imaging candidate, CD8 ImmunoPET, which is currently in Phase 2 clinical trials and has been licensed by numerous pharmaceutical ...
A progressively higher-intensity walking exercise program combined with standard physical therapy significantly improved the quality of life and mobility in stroke survivors, according to a ...